"专家访谈"标签列表

[EASL2014]WHO丙肝指南将影响各个国家的政策——Stefan Wiktor博士访谈2014-05-19

[EASL2014]丙肝贫血患者应减低药量继续治疗，无感染的失代偿患者可用β受体阻滞剂治疗——大会秘书长Markus Peck-Radosavljevic教授访谈2014-04-23

[EASL2014]EASL2014名誉主席：更为便捷和扩大化的知识交流更好地为全球肝病学者服务——Giorgina Mieli-Vergani教授访谈2014-04-16

[APASL2014]Controlling hepatitis B:Will we ever eradicate it?——Interview with Dr.Stephen Locarnini2014-03-14

[APASL2014]亚太地区肝病障碍之二：乙肝负担认识误区——Stephen Locarnini教授访谈2014-03-14

[APASL2014]Barriers to Treating Liver Disease in the Asia-Pacific：Organ Donation——Interview with Prof.Chung Mau Lo2014-03-14

[APASL2014]亚太地区肝病障碍之三：供体不足——卢宠茂教授访谈2014-03-14

[APASL2014]Hepatitis and HIV co-infection in the Asia Pacific Region——Interview with Prof.Gregory Dore2014-03-14

[APASL2014]亚太地区肝脏疾病障碍之一：HCV与HIV合并感染——澳大利亚新南威尔士大学Gregory Dore博士访谈2014-03-14

[APASL2014]HCC Epidemiology and Risk Factors in the Asia-Pacific——Interview With Prof.Man-Fung Yuen2014-03-14

[APASL2014]Progress and Prospect of the Prevention and Control of Hepatitis——Interview with Mr.Charles Gore2014-03-14

[APASL2014]非酒精性脂肪性肝炎的降脂治疗——Geoff Farrell教授访谈2014-03-14

[APASL2014]Lipid-Lowering in NASH——Interview With Prof.Geoff Farrell2014-03-14

[APASL2014]CEVHAP and the Fight to End Viral Hepatitis——Interview with Prof.Ding-Shinn Chen2014-03-14

[APASL2014]CEVHAP与终结病毒性肝炎的斗争——陈定信教授访谈2014-03-14

[APASL2014]乙型肝炎疾病进展影响因素知多少——高嘉宏教授访谈2014-03-13

[APASL2014]Mother-to-Infant Transmission of Hepatitis B——Interview with Prof.Ji-Dong Jia2014-03-13

[APASL2014]HBIG Is Being Phased Out!——Interview with Dr.James Fung2014-03-13

[APASL2014]Treatment end points of Hepatitis B:What they are and How to achieve?——Interview with Prof.Jia-Horng Kao2014-03-13

[APASL2014]Asia-Pacific Region: The Epicentre of Liver Disease——Interview with Prof.Darrell Crawford2014-03-13